Indias GLP-1 Drug Race is Heating Up From diabetes care to weight management, GLP-1 therapies are redefining modern medicine and Indian pharma is stepping in at scale
Trials that started with lower initial doses and escalated more gradually showed reduced nausea severity compared to earlier protocols that escalated faster
It does this in two ways: by triggering extra insulin, a hormone that helps lower blood sugar levels, and by inhibiting glucagon, a hormone that raises blood sugar levels
Billing and renewal
However, because these cells remain susceptible to autoimmune attack, all recipients require potent systemic immunosuppression (e.g., thymoglobulin and tacrolimus), substantially limiting broader applicability
The study showed notable reductions in the risk of endometrial cancer and meningiomas, a type of brain tumor